Quick answer
Republic Services, Inc. (RSG) reported revenue of $19.03B and net income of $2.14B for the fiscal year ended 2025-12-31, up 3.3% from $18.42B the year before, per its 10-K filed with the SEC on 2026-02-18. Long-term debt stood at $13.71B.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $19.03B | $2.14B | $13.71B |
| 2024 (FY ending 2024-12-31) | $18.42B | $2.04B | $12.84B |
| 2023 (FY ending 2023-12-31) | $17.28B | $1.73B | $12.82B |
| 2022 (FY ending 2022-12-31) | $15.64B | $1.49B | $11.90B |
| 2021 (FY ending 2021-12-31) | $13.32B | $1.29B | $9.68B |
| 2020 (FY ending 2020-12-31) | $12.03B | $967.2M | $9.05B |
| 2019 (FY ending 2019-12-31) | $12.19B | $1.07B | $8.79B |
| 2018 (FY ending 2018-12-31) | $11.90B | $1.04B | $8.45B |
| 2017 (FY ending 2017-12-31) | $12.07B | $1.28B | — |
| 2016 (FY ending 2016-12-31) | $11.36B | $612.6M | — |
Related
- RRC revenue, net income and debt history (Range Resources Corp)
- RRX revenue, net income and debt history (Regal Rexnord Corp)
- RS revenue, net income and debt history (Reliance, Inc.)
- RTX revenue, net income and debt history (Rtx Corporation)
- RVMD revenue, net income and debt history (Revolution Medicines, Inc.)
- RVTY revenue, net income and debt history (Revvity, Inc)
- RYAN revenue, net income and debt history (Ryan Specialty Holdings, Inc.)
- S revenue, net income and debt history (Sentinelone, Inc)
Last updated 2026-10-16. Data only, not financial or tax advice.